Add like
Add dislike
Add to saved papers

Estimate Gaps of Montreal Protocol-Regulated Potent Greenhouse Gas HFC-152a Emissions in China Have Been Explained.

1,1-Difluoroethane (HFC-152a) is a hydrofluorocarbon regulated by the Montreal Protocol, and its emissions in China are of concern as China will regulate HFC-152a in 2024. However, no observation-inferred top-down estimates were undertaken after 2017, and substantial gaps existed among previous estimates of China's HFC-152a emissions. Using the atmospheric observations and inverse modeling, this study reveals China's HFC-152a emissions of 9.4 ± 1.7 Gg/yr (gigagrams per year), 10.6 ± 1.8 Gg/yr, and 9.7 ± 1.5 Gg/yr in 2018, 2019, and 2020, respectively. In addition, we display an overall increasing trend during 2011-2020, which is in contrast to the decreasing and steady trend reported by the Emission Database for Global Atmospheric Research (EDGAR) and the Chinese government, respectively. Subsequently, we establish a comprehensive bottom-up emission inventory matching with top-down estimates and thus succeed in explaining the gaps among previous estimates. Furthermore, the contribution of China's emissions to global HFC-152a emission growth increased from 15% during 2001-2010 to >100% during 2011-2020. An emission projection based on our improved inventory shows that the Kigali Amendment (KA) would assist in avoiding 1535.6-4710.6 Gg (251.8-772.5 Tg CO2 -eq) HFC-152a emissions during 2024-2100. Our findings indicate relatively accurate China's HFC-152a emissions and provide scientific support for addressing climate change and implementing the KA.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app